Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2025 Earnings Call Transcript March 4, 2026
Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.53, expectations were $-1.19.
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time, all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today’s conference call may be recorded. I would now like to hand the...
